Compounds > 5,8,11-eicosatriynoic acid
Page last updated: 2024-10-21

5,8,11-eicosatriynoic acid and Atherosclerosis

5,8,11-eicosatriynoic acid has been researched along with Atherosclerosis in 1 studies

5,8,11-eicosatriynoic acid: a lipoxygenase inhibitor
5,8,11-icosatriynoic acid : A C20 polyunsaturated fatty acid having three triple bonds in the 5-, 8- and 11-positions.

Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kälvegren, H1
Bylin, H1
Leanderson, P1
Richter, A1
Grenegård, M1
Bengtsson, T1

Other Studies

1 other study available for 5,8,11-eicosatriynoic acid and Atherosclerosis

ArticleYear
Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Effects on oxidation of low density lipoproteins.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:2

    Topics: Atherosclerosis; Blood Platelets; Cells, Cultured; Chlamydophila pneumoniae; Enzyme Inhibitors; Fatt

2005